Frank McCormick, Chairman of Oncology at BridgeBio Pharma, Inc. (BBIO), sold 81,250 shares at $40.13 ($3.1M) on 2019-12-27, disclosed to the SEC on 2019-12-31.
Open-market sale of $3.1M BBIO by Chairman of Oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.37 | 25,531 | $929K | 30.2% |
| 2 | $36.85 | 21,656 | $798K | 26.0% |
| 3 | $38.09 | 3,500 | $133K | 4.3% |
| 4 | $39.27 | 13,705 | $538K | 17.5% |
| 5 | $40.13 | 16,858 | $677K | 22.0% |
| Total | $37.84 avg | 81,250 |
| $3.1M |
| 100% |
| Filing → |
| BBIO | SELL | 2025-09-08 | $7.9M | — | Filing → |
| BBIO | SELL | 2025-06-26 | $4.4M | — | Filing → |
| BBIO | SELL | 2023-12-28 | $4.2M | — | Filing → |